{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T11:48:07Z","timestamp":1794570487997,"version":"4.9.1"},"reference-count":38,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Various papers have introduced the use of positron emission tomography (PET) with [68Ga]Ga-radiolabeled fibroblast-activation protein inhibitor (FAPi) radiopharmaceuticals in different subtypes of gastric cancer (GC). Our aim was to assess the diagnostic performance of this novel molecular imaging technique in GC with a systematic review and meta-analysis. A straightforward literature search of papers concerning the diagnostic performance of FAP-targeted PET imaging was performed. Original articles evaluating this novel molecular imaging examination in both newly diagnosed GC patients and GC patients with disease relapse were included. The systematic review included nine original studies, and eight of them were also eligible for meta-analysis. The quantitative synthesis provided pooled detection rates of 95% and 97% for the assessment of primary tumor and distant metastases, respectively, and a pooled sensitivity and specificity of 74% and 89%, respectively, for regional lymph node metastases. Significant statistical heterogeneity among the included studies was found only in the analysis of the primary tumor detection rate (I2 = 64%). Conclusions: Beyond the limitations of this systematic review and meta-analysis (i.e., all the included studies were conducted in Asia, and using [18F]FDG PET\/CT as a comparator of the index test), the quantitative data provided demonstrate the promising diagnostic performance of FAP-targeted PET imaging in GC. Nevertheless, more prospective multicentric studies are needed to confirm the excellent performances of FAP-targeted PET in this cluster of patients.<\/jats:p>","DOI":"10.3390\/ijms241210136","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T01:32:57Z","timestamp":1686792777000},"page":"10136","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"24","author":[{"given":"Alessio","family":"Rizzo","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Candiolo Cancer Institute, FPO-IRCCS, 10060 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9350-1239","authenticated-orcid":false,"given":"Manuela","family":"Racca","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Candiolo Cancer Institute, FPO-IRCCS, 10060 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Garrou","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, Department of Medical Sciences, AOU Citt\u00e0 della Salute e della Scienza, University of Turin, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6679-0955","authenticated-orcid":false,"given":"Elisabetta","family":"Fenocchio","sequence":"additional","affiliation":[{"name":"Department of Oncology, Candiolo Cancer Institute, FPO-IRCCS, 10060 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Pellegrino","sequence":"additional","affiliation":[{"name":"Department of Surgery, Candiolo Cancer Institute, FPO-IRCCS, 10060 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0810-6494","authenticated-orcid":false,"given":"Domenico","family":"Albano","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Universit\u00e0 degli Studi di Brescia and ASST Spedali Civili di Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4839-9033","authenticated-orcid":false,"given":"Francesco","family":"Dondi","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Universit\u00e0 degli Studi di Brescia and ASST Spedali Civili di Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bertagna","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Universit\u00e0 degli Studi di Brescia and ASST Spedali Civili di Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Annunziata","sequence":"additional","affiliation":[{"name":"Unit\u00e0 di Medicina Nucleare, GSTeP Radiopharmacy\u2014TracerGLab, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9808-780X","authenticated-orcid":false,"given":"Giorgio","family":"Treglia","sequence":"additional","affiliation":[{"name":"Clinic of Nuclear Medicine, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, 6501 Bellinzona, Switzerland"},{"name":"Faculty of Biology and Medicine, University of Lausanne, 1011 Lausanne, Switzerland"},{"name":"Faculty of Biomedical Sciences, Universit\u00e0 della Svizzera Italiana, 6900 Lugano, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"13842","DOI":"10.3748\/wjg.v20.i38.13842","article-title":"Gastric Cancer: Prevention, Screening and Early Diagnosis","volume":"20","author":"Pasechnikov","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Machlowska, J., Baj, J., Sitarz, M., Maciejewski, R., and Sitarz, R. (2020). Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21114012"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","article-title":"The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. an attempt at a histo-clinical classification","volume":"64","author":"Lauren","year":"1965","journal-title":"Acta Pathol. Microbiol. Scand"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/ejhg.2017.138","article-title":"Unraveling Genetic Predisposition to Familial or Early Onset Gastric Cancer Using Germline Whole-Exome Sequencing","volume":"25","author":"Vogelaar","year":"2017","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1048922","DOI":"10.3389\/fonc.2023.1048922","article-title":"Cancer-Associated Fibroblasts, and Clinicopathological Characteristics and Prognosis of Gastric Cancer: A Systematic Review and Meta-Analysis","volume":"13","author":"Wei","year":"2023","journal-title":"Front. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric Cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"ref_7","first-page":"CD009944","article-title":"Diagnostic Accuracy of Endoscopic Ultrasonography (EUS) for the Preoperative Locoregional Staging of Primary Gastric Cancer","volume":"2015","author":"Mocellin","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"20220437","DOI":"10.1259\/bjr.20220437","article-title":"The Impact of Baseline 18F-FDG PET-CT on the Management and Outcome of Patients with Gastric Cancer: A Systematic Review","volume":"95","author":"Foley","year":"2022","journal-title":"Br. J. Radiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A Framework for Advancing Our Understanding of Cancer-Associated Fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","article-title":"Clinical and Therapeutic Relevance of Cancer-Associated Fibroblasts","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1158\/1078-0432.CCR-20-4226","article-title":"Molecular Features of Cancer-Associated Fibroblast Subtypes and Their Implication on Cancer Pathogenesis, Prognosis, and Immunotherapy Resistance","volume":"27","author":"Galbo","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1007\/s00259-023-06179-3","article-title":"FAPI PET\/CT in Infectious, Inflammatory, and Rheumatological Diseases: \u201cWatch It like a Hawk\u201d or \u201cOne Swallow Does Not Make a Summer\u201d?","volume":"50","author":"Treglia","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Gilardi, L., Air\u00f2 Farulla, L.S., Demirci, E., Clerici, I., Omodeo Sal\u00e8, E., and Ceci, F. (2022). Imaging Cancer-Associated Fibroblasts (CAFs) with FAPi PET. Biomedicines, 10.","DOI":"10.20944\/preprints202201.0327.v1"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s00259-021-05441-w","article-title":"Comparison of [68 Ga]Ga-FAPI-04 and [18F]-FDG for the Detection of Primary and Metastatic Lesions in Patients with Gastric Cancer: A Bicentric Retrospective Study","volume":"49","author":"Jiang","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00259-021-05494-x","article-title":"Head-to-Head Comparison of [68Ga]Ga-FAPI-04 and [18F]-FDG PET\/CT in Evaluating the Extent of Disease in Gastric Adenocarcinoma","volume":"49","author":"Kuten","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"802257","DOI":"10.3389\/fonc.2021.802257","article-title":"PET\/CT Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients","volume":"11","author":"Rong","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/MNM.0000000000001607","article-title":"Comparison of 18F-FDG PET\/CT and 68Ga-FAPI-04 PET\/CT in the Staging and Restaging of Gastric Adenocarcinoma","volume":"43","author":"Can","year":"2022","journal-title":"Nucl. Med. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1007\/s00259-022-05799-5","article-title":"[68Ga]Ga-DOTA-FAPI-04 PET\/CT in the Evaluation of Gastric Cancer: Comparison with [18F]FDG PET\/CT","volume":"49","author":"Lin","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_19","first-page":"1453","article-title":"Utility of [68Ga]FAPI-04 and [18F]FDG Dual-Tracer PET\/CT in the Initial Evaluation of Gastric Cancer","volume":"370","author":"Miao","year":"2022","journal-title":"Eur. Radiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2967\/jnumed.120.258467","article-title":"68Ga-DOTA-FAPI-04 PET\/MR in the Evaluation of Gastric Carcinomas: Comparison with 18F-FDG PET\/CT","volume":"63","author":"Qin","year":"2022","journal-title":"J. Nucl. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"925100","DOI":"10.3389\/fonc.2022.925100","article-title":"Comparison of Diagnostic Efficacy of [68Ga]Ga-FAPI-04 and [18F]FDG PET\/CT for Staging and Restaging of Gastric Cancer","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00330-022-09084-9","article-title":"Comparison of [68Ga]Ga-FAPI and [18F]FDG Uptake in Patients with Gastric Signet-Ring-Cell Carcinoma: A Multicenter Retrospective Study","volume":"33","author":"Chen","year":"2023","journal-title":"Eur. Radiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"68Ga-FAPI PET\/CT: Tracer Uptake in 28 Different Kinds of Cancer","volume":"60","author":"Kratochwil","year":"2019","journal-title":"J. Nucl. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00259-020-04940-6","article-title":"Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET\/CT in Patients Presenting with Inconclusive [18F]FDG PET\/CT Findings","volume":"48","author":"Chen","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2967\/jnumed.119.236786","article-title":"Radiation Dosimetry and Biodistribution of 68Ga-FAPI-46 PET Imaging in Cancer Patients","volume":"61","author":"Meyer","year":"2020","journal-title":"J. Nucl. Med."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Bentestuen, M., Al-Obaydi, N., and Zacho, H.D. (Semin. Nucl. Med., 2023). FAPI-Avid Nonmalignant PET\/CT Findings: An Expedited Systematic Review, Semin. Nucl. Med., in press.","DOI":"10.1053\/j.semnuclmed.2023.02.001"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1007\/s00259-020-05146-6","article-title":"Role of [68Ga]Ga-DOTA-FAPI-04 PET\/CT in the Evaluation of Peritoneal Carcinomatosis and Comparison with [18F]-FDG PET\/CT","volume":"48","author":"Zhao","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1470-2045(16)00175-3","article-title":"Pembrolizumab for Patients with PD-L1-Positive Advanced Gastric Cancer (KEYNOTE-012): A Multicentre, Open-Label, Phase 1b Trial","volume":"17","author":"Muro","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e180013","DOI":"10.1001\/jamaoncol.2018.0013","article-title":"Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial","volume":"4","author":"Fuchs","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_30","first-page":"1210","article-title":"Validation of FLT Uptake as a Measure of Thymidine Kinase-1 Activity in A549 Carcinoma Cells","volume":"43","author":"Rasey","year":"2002","journal-title":"J. Nucl. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00261-016-0788-6","article-title":"FLT-PET\/CT Diagnosis of Primary and Metastatic Nodal Lesions of Gastric Cancer: Comparison with FDG-PET\/CT","volume":"41","author":"Nakajo","year":"2016","journal-title":"Abdom. Radiol."},{"key":"ref_32","first-page":"696423","article-title":"(18)F-FLT PET\/CT in Patients with Gastric Carcinoma","volume":"2013","author":"Staniuk","year":"2013","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_33","first-page":"165","article-title":"Evaluation of FLT-PET\/CT Usefulness in Diagnosis and Qualification for Surgical Treatment of Gastric Cancer","volume":"17","author":"Staniuk","year":"2013","journal-title":"Contemp. Oncol. (Pozn)"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3948873","DOI":"10.1155\/2022\/3948873","article-title":"Could Fibroblast Activation Protein (FAP)-Specific Radioligands Be Considered as Pan-Tumor Agents?","volume":"2022","author":"Roustaei","year":"2022","journal-title":"Contrast Media Mol. Imaging."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Treglia, G., Muoio, B., Roustaei, H., Kiamanesh, Z., Aryana, K., and Sadeghi, R. (2021). Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers versus [18F]F-FDG in Oncology: A Systematic Review. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222011192"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40001-023-00997-9","article-title":"[68Ga]Ga-FAPI-04 PET MRI\/CT in the Evaluation of Gastric Carcinomas Compared with [18F]-FDG PET MRI\/CT: A Meta-Analysis","volume":"28","author":"Wang","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40336-016-0219-2","article-title":"Systematic Reviews and Meta-Analyses of Diagnostic Studies: A Practical Guideline","volume":"5","author":"Sadeghi","year":"2017","journal-title":"Clin. Transl. Imaging"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/12\/10136\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:55:04Z","timestamp":1760126104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/12\/10136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["ijms241210136"],"URL":"https:\/\/doi.org\/10.3390\/ijms241210136","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,14]]}}}